These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8615117)

  • 1. From basal ganglia to motoneurons. Probable involvement of pathways relaying in the medulla.
    Delwaide PJ; Pepin JL; Maertens de Noordhout A
    Adv Neurol; 1996; 69():111-6. PubMed ID: 8615117
    [No Abstract]   [Full Text] [Related]  

  • 2. Functional neuroanatomy of the basal ganglia in Parkinson's disease.
    Wichmann T; DeLong MR
    Adv Neurol; 2003; 91():9-18. PubMed ID: 12442660
    [No Abstract]   [Full Text] [Related]  

  • 3. Physiology and pathophysiology of the basal ganglia-thalamo-cortical networks.
    Rosin B; Nevet A; Elias S; Rivlin-Etzion M; Israel Z; Bergman H
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S437-9. PubMed ID: 18267279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal ganglia oscillations and pathophysiology of movement disorders.
    Rivlin-Etzion M; Marmor O; Heimer G; Raz A; Nini A; Bergman H
    Curr Opin Neurobiol; 2006 Dec; 16(6):629-37. PubMed ID: 17084615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortico-basal ganglia-cortical circuitry in Parkinson's disease reconsidered.
    Braak H; Del Tredici K
    Exp Neurol; 2008 Jul; 212(1):226-9. PubMed ID: 18501351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinson's disease is a neuropsychiatric disorder.
    Agid Y; Arnulf I; Bejjani P; Bloch F; Bonnet AM; Damier P; Dubois B; François C; Houeto JL; Iacono D; Karachi C; Mesnage V; Messouak O; Vidailhet M; Welter ML; Yelnik J
    Adv Neurol; 2003; 91():365-70. PubMed ID: 12442695
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of the subthalamic nucleus in the pathophysiology of Parkinson's disease.
    Blandini F
    Funct Neurol; 2001; 16(4 Suppl):99-106. PubMed ID: 11996537
    [No Abstract]   [Full Text] [Related]  

  • 8. Localization of adenosine A2A receptors in brain: therapeutic implications.
    Augood SJ
    Adv Neurol; 1999; 80():105-9. PubMed ID: 10410708
    [No Abstract]   [Full Text] [Related]  

  • 9. Stn-dbs activates the target area in Parkinson disease.
    Montgomery EB; Hilker R
    Neurology; 2009 Jul; 73(4):327; author reply 327-8. PubMed ID: 19636056
    [No Abstract]   [Full Text] [Related]  

  • 10. Oscillations in the basal ganglia under normal conditions and in movement disorders.
    Gatev P; Darbin O; Wichmann T
    Mov Disord; 2006 Oct; 21(10):1566-77. PubMed ID: 16830313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Patterns of neuronal activity in the basal ganglia nucleus in parkinsonian patients with levodopa-induced dyskinesia].
    Li XY; Zhuang P; Li YJ
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(23):1607-12. PubMed ID: 19035099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal ganglia: functional perspectives and behavioral domains.
    Saint-Cyr JA
    Adv Neurol; 2005; 96():1-16. PubMed ID: 16383208
    [No Abstract]   [Full Text] [Related]  

  • 13. The basal ganglia circuits, dopamine, and ambiguous word processing: a neurobiological account of priming studies in Parkinson's disease.
    Chenery HJ; Angwin AJ; Copland DA
    J Int Neuropsychol Soc; 2008 May; 14(3):351-64. PubMed ID: 18419834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional anatomy of thalamus and basal ganglia.
    Herrero MT; Barcia C; Navarro JM
    Childs Nerv Syst; 2002 Aug; 18(8):386-404. PubMed ID: 12192499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential nondopaminergic drugs for Parkinson's disease.
    Silverdale MA; Fox SH; Crossman AR; Brotchie JM
    Adv Neurol; 2003; 91():273-91. PubMed ID: 12442686
    [No Abstract]   [Full Text] [Related]  

  • 16. Subcortical aphasia: still a useful concept?
    Cappa SF
    Brain Lang; 1997 Jul; 58(3):424-6; discussion 436-58. PubMed ID: 9222522
    [No Abstract]   [Full Text] [Related]  

  • 17. Improvement of parkinsonian signs after vascular lesions of the basal ganglia circuitry.
    Krauss JK; Grossman RG; Jankovic J
    Mov Disord; 1997 Jan; 12(1):124-6. PubMed ID: 8990069
    [No Abstract]   [Full Text] [Related]  

  • 18. [Physiopathology of the Parkinsonian syndrome].
    Mamo H
    Ann Med Interne (Paris); 1972 Apr; 123(4):341-7. PubMed ID: 5077038
    [No Abstract]   [Full Text] [Related]  

  • 19. Neurophysiological aspects of Parkinson's disease.
    Voorhoeve PE
    Psychiatr Neurol Neurochir; 1970; 73(5):329-38. PubMed ID: 4250146
    [No Abstract]   [Full Text] [Related]  

  • 20. [Neurobiology of parkinsonism. I. Neural substrates an neurochemistry of the basal ganglia].
    Ponzoni S; Garcia-Cairasco N
    Arq Neuropsiquiatr; 1995 Sep; 53(3-B):706-10. PubMed ID: 8585835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.